Funding for this research was provided by:
KWF Kankerbestrijding (11632/2018-1)
Received: 4 December 2020
Accepted: 10 May 2021
First Online: 7 June 2021
: The authors declare the following competing interests: W.d.L., E.S., M.v.M. are founders and shareholder of Cergentis. J.S., M.Y., K.H., M.v.M., H.F., E.S. are employees of Cergentis. The remaining authors declare no competing interests. A list of patents and patent applications related to this work can be found in Suppl. Table 4.